开始
AlenCiken

CLBS granted regenerative medicine advanced therapy by FDA

做多
AlenCiken  
NASDAQ:CLBS   None
Trend Analysis Chart Patterns Technical Indicators
2
0
trendanalysis chartpattern indicator
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina

www.caladrius.com/pr...g-refractory-angina/
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。